Small Molecules
7 August 2014
Enanta Pharmaceuticals’ HCV NS5A Inhibitor EDP-239 Advances into Combination Studies with Alisporivir (DEB025)6 August 2014
Celsus Therapeutics Plc Announces First Patient Enrolled in Phase II Trial of MRX-6 in Pediatric Atopic Dermatitis6 August 2014
Cara Therapeutics Initiates Proof-of-Concept Phase II Trial of I.V. CR845 in Uremic Pruritus6 August 2014
New Data Shows High Efficacy for Can-Fite’s CF101 in Rheumatoid Arthritis and Psoriasis Patients6 August 2014
Trevena Initiates Phase 1 Multiple Ascending Dose Study of TRV734 for Acute and Chronic Pain6 August 2014
Egalet Announces Topline Results From Bioequivalence Studies of Abuse-Deterrent Morphine, Egalet-0015 August 2014
MediciNova Announces Positive Results of MN-001 in Advanced NASH Mouse Model; MediciNova Requests a Meeting With FDA5 August 2014
FDA Accepts Supplemental New Drug Application for Jakafi® (ruxolitinib) and Priority Review Granted5 August 2014
NPS Pharma Initiates Phase 2a Study of NPSP795 in Adult Patients with Autosomal Dominant Hypocalcemia (ADH)4 August 2014
Insmed Provides Regulatory Update for ARIKAYCE1 August 2014
Alexza Provides Pipeline UpdateNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports